THE COOPER COMPANIES, INC. Funds and ETFs The Cooper Companies, Inc.
Equities
COO
US2166485019
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.11 USD | -0.97% |
|
-4.99% | -7.89% |
ETFs positioned on The Cooper Companies, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.51% | 7 M€ | +4.63% | ||
| 1.32% | 2 M€ | +8.54% | ||
| 0.59% | 4,592 M€ | -.--% | ||
| 0.58% | 21 M€ | +9.20% | - | |
| 0.24% | 3,859 M€ | +18.82% | - | |
| 0.24% | 469 M€ | -2.05% | ||
| 0.23% | 1 M€ | +11.94% | - | |
| 0.23% | 3 M€ | +7.32% | - | |
| 0.23% | 13 M€ | -.--% | - | |
| 0.22% | 29 M€ | -.--% | - | |
| 0.22% | 322 M€ | -.--% | - | |
| 0.22% | 414 M€ | +17.91% | - | |
| 0.22% | 1,006 M€ | -.--% | - | |
| 0.19% | 9 M€ | -.--% | - | |
| 0.18% | 2 M€ | +20.44% | - | |
| 0.15% | 5 M€ | -72.95% | - | |
| 0.12% | 8 M€ | +4.96% | - | |
| 0.12% | 31 M€ | -0.25% | - | |
| 0.12% | 20 M€ | +4.96% | - | |
| 0.10% | 1,448 M€ | -.--% | - | |
| 0.10% | 219 M€ | +17.17% | - | |
| 0.09% | 2 M€ | +14.69% | - | |
| 0.09% | 330 M€ | -.--% | - | |
| 0.07% | 276 M€ | +11.40% | - | |
| 0.07% | 9 M€ | +9.76% | - | |
| 0.07% | 825 M€ | +14.04% | ||
| 0.06% | 55 M€ | +14.34% | ||
| 0.05% | 6 M€ | +17.98% | - |
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Calendar
29/08/2024
- Q3 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
87.96
USD
Average target price
109.7
USD
Spread / Average Target
+24.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.89% | 1.75TCr | |
| +11.78% | 10TCr | |
| -29.23% | 202.49Cr | |
| +14.75% | 189.23Cr | |
| +20.93% | 115.42Cr | |
| +70.25% | 68Cr | |
| -11.01% | 65Cr | |
| -47.06% | 63Cr | |
| -43.70% | 62Cr | |
| +28.34% | 55Cr |
- Stock Market
- Equities
- COO Stock
- Funds and ETFs The Cooper Companies, Inc.
